Oncology

Recent advances and updates in oncology and cancer drug development.

Top news of the day from across the health care landscape.

An award of $55 million will help launch different infrastructure needed to improve precision medicine.

Surgery combined with chemotherapy and radiation may be a good option for pancreatic cancer patients whose tumors involved blood vessels.

Chimeric antigen receptor T cell therapy targets advanced forms of leukemia and lymphoma.

Some tumors can remain undetected from current cancer treatments.

A new study’s findings contradict previous assumptions about IVF and breast cancer risk.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Is the cost of specialty drugs worth the price in small patient populations?

Phase 2 clinical trial of brentuximab vedotin (Adcetris) monotherapy in relapsed or refractory classical Hodgkin lymphoma treatment shows improved survival.

Obinutuzumab not found to improve progression-free survival in untreated diffuse large B-cell lymphoma.

Notch signaling pathway found to drive prostate cancer metastasis.

Top news of the day from across the health care landscape.

Self-reported prevalence of prostate cancer found lower in men who take aspirin.

The cancer mortality rate declined 1.55 % in 2011.

Benign meningioma tumors may be less likely in patients with high blood sugar.

Patients who underwent gross total resection had a significantly increased 1-year survival rate.

Even in early clinical trials for cancer drugs, the use of precision medicine showed longer progression-free survival.

Patients in their 50s and 60s were more likely to be diagnosed with late stage lung cancer compared with older patients.

The absence of O-glycan sugars led to colitis and colon cancer in mouse models.

Mouse models of paclitaxel lower than clinical doses showed an increase of liver metastases.

Nanostructured lipid carriers filled with melatonin may boost chemotherapy efficacy.

Approximately 38% of women who had initial echocardiograms received a follow-up scan.

Women who undergo surgery for ovarian cancer lived four times longer than women who did not.

Restriction spectrum imaging distinguishes between different prostate cancer tumor grades.

Proteogenomic analysis expands knowledge into breast cancer therapy.

Avella Specialty Pharmacy has distributed its fifth issue of Dispensing Excellence, a publication for healthcare providers, nurses, medical assistants and their patients.